Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific 
vulnerabilities as potential treatment options of proteasome 
inhibitor-resistant multiple myeloma

Andrej, B.; Lenka, B.; Buchler, L.; Stolze, S.; Sobh, A.; Kraus, M.; Nakagami, H.; Driessen, C.

Local TagsRelease HistoryDetailsSummary

Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma

Andrej, B., Lenka, B., Buchler, L., Stolze, S., Sobh, A., Kraus, M., et al. (2021). Genome-wide CRISPR/Cas9 screening identifies proteasome-related specific vulnerabilities as potential treatment options of proteasome inhibitor-resistant multiple myeloma. Clinical Lymphoma Myeloma and Leukemia, 21, S88-S89.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-000A-3033-6 Version Permalink: https://hdl.handle.net/21.11116/0000-000A-3034-5

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Andrej, B.¹, Author
Lenka, B.¹, Author
Buchler, L.¹, Author
Stolze, S.², Author
Sobh, A.¹, Author
Kraus, M.¹, Author
Nakagami, H.², Author
Driessen, C.¹, Author

Affiliations:
1external, ou_persistent22
2Mass Spectrometry, MPI for Plant Breeding Research, Max Planck Society, ou_1113575

Content

show

Details

show

hide

Language(s): eng - English

Dates: Published Online: 2021Date issued: 2021

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: -

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: Clinical Lymphoma Myeloma and Leukemia

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA : CIG MEDIA GROUP, LP

Pages: - Volume / Issue: 21 Sequence Number: - Start / End Page: S88 - S89 Identifier: -